Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation

N. Nicoli Aldini, P. Caliceti, S. Lora, M. Fini, G. Giavaresi, M. Rocca, P. Torricelli, R. Giardino, F. M. Veronese

Research output: Contribution to journalArticle

Abstract

Bioabsorbable polyphosphazene matrices charged with 250 μg calcitonin were evaluated as calcitonin delivery systems for the controlled release of this drug in an in vivo experimental model. Matrices were implanted under general anesthesia in osteopenic female rats, while a group of osteopenic animals (control group) received unloaded matrices. After 30 days a second series of matrices, loaded and unloaded was, respectively, implanted in both groups. In a third group of osteopenic female rats (positive control), 10 IU calcitonin were injected daily for two months. A baseline group and a sham operated group of animals were also included in the study. The explanted matrices were histologically evaluated together with the surrounding tissues, and bone histomorphometry was performed on undecalcified sections from femurs. The results showed the good biocompatibility of the matrices. Bone histomorphometry revealed that bone architecture in the treatment group was improved and results were not different from those observed after calcitonin injection. These data confirm a good in vivo behavior of the system, as well as a therapeutic effect of the released calcitonin in the osteopenic condition.

Original languageEnglish
Pages (from-to)955-961
Number of pages7
JournalJournal of Orthopaedic Research
Volume19
Issue number5
DOIs
Publication statusPublished - 2001

Fingerprint

Calcitonin
Osteoporosis
Bone and Bones
Therapeutics
Therapeutic Uses
Femur
General Anesthesia
Theoretical Models
Control Groups
Injections

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation. / Aldini, N. Nicoli; Caliceti, P.; Lora, S.; Fini, M.; Giavaresi, G.; Rocca, M.; Torricelli, P.; Giardino, R.; Veronese, F. M.

In: Journal of Orthopaedic Research, Vol. 19, No. 5, 2001, p. 955-961.

Research output: Contribution to journalArticle

@article{7dcea533e5a5458a99ddd1543facb178,
title = "Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation",
abstract = "Bioabsorbable polyphosphazene matrices charged with 250 μg calcitonin were evaluated as calcitonin delivery systems for the controlled release of this drug in an in vivo experimental model. Matrices were implanted under general anesthesia in osteopenic female rats, while a group of osteopenic animals (control group) received unloaded matrices. After 30 days a second series of matrices, loaded and unloaded was, respectively, implanted in both groups. In a third group of osteopenic female rats (positive control), 10 IU calcitonin were injected daily for two months. A baseline group and a sham operated group of animals were also included in the study. The explanted matrices were histologically evaluated together with the surrounding tissues, and bone histomorphometry was performed on undecalcified sections from femurs. The results showed the good biocompatibility of the matrices. Bone histomorphometry revealed that bone architecture in the treatment group was improved and results were not different from those observed after calcitonin injection. These data confirm a good in vivo behavior of the system, as well as a therapeutic effect of the released calcitonin in the osteopenic condition.",
author = "Aldini, {N. Nicoli} and P. Caliceti and S. Lora and M. Fini and G. Giavaresi and M. Rocca and P. Torricelli and R. Giardino and Veronese, {F. M.}",
year = "2001",
doi = "10.1016/S0736-0266(00)00074-7",
language = "English",
volume = "19",
pages = "955--961",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation

AU - Aldini, N. Nicoli

AU - Caliceti, P.

AU - Lora, S.

AU - Fini, M.

AU - Giavaresi, G.

AU - Rocca, M.

AU - Torricelli, P.

AU - Giardino, R.

AU - Veronese, F. M.

PY - 2001

Y1 - 2001

N2 - Bioabsorbable polyphosphazene matrices charged with 250 μg calcitonin were evaluated as calcitonin delivery systems for the controlled release of this drug in an in vivo experimental model. Matrices were implanted under general anesthesia in osteopenic female rats, while a group of osteopenic animals (control group) received unloaded matrices. After 30 days a second series of matrices, loaded and unloaded was, respectively, implanted in both groups. In a third group of osteopenic female rats (positive control), 10 IU calcitonin were injected daily for two months. A baseline group and a sham operated group of animals were also included in the study. The explanted matrices were histologically evaluated together with the surrounding tissues, and bone histomorphometry was performed on undecalcified sections from femurs. The results showed the good biocompatibility of the matrices. Bone histomorphometry revealed that bone architecture in the treatment group was improved and results were not different from those observed after calcitonin injection. These data confirm a good in vivo behavior of the system, as well as a therapeutic effect of the released calcitonin in the osteopenic condition.

AB - Bioabsorbable polyphosphazene matrices charged with 250 μg calcitonin were evaluated as calcitonin delivery systems for the controlled release of this drug in an in vivo experimental model. Matrices were implanted under general anesthesia in osteopenic female rats, while a group of osteopenic animals (control group) received unloaded matrices. After 30 days a second series of matrices, loaded and unloaded was, respectively, implanted in both groups. In a third group of osteopenic female rats (positive control), 10 IU calcitonin were injected daily for two months. A baseline group and a sham operated group of animals were also included in the study. The explanted matrices were histologically evaluated together with the surrounding tissues, and bone histomorphometry was performed on undecalcified sections from femurs. The results showed the good biocompatibility of the matrices. Bone histomorphometry revealed that bone architecture in the treatment group was improved and results were not different from those observed after calcitonin injection. These data confirm a good in vivo behavior of the system, as well as a therapeutic effect of the released calcitonin in the osteopenic condition.

UR - http://www.scopus.com/inward/record.url?scp=0034865828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034865828&partnerID=8YFLogxK

U2 - 10.1016/S0736-0266(00)00074-7

DO - 10.1016/S0736-0266(00)00074-7

M3 - Article

C2 - 11562147

AN - SCOPUS:0034865828

VL - 19

SP - 955

EP - 961

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 5

ER -